Evidence map›Paper›PMID 24968940›Full record

ArticleScience (New York, N.Y.)2014

Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter.

T A Reese, B S Wakeman, H S Choi, M M Hufford, S C Huang, X Zhang, M D Buck, A Jezewski, A Kambal, C Y Liu and 9 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 2 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 2 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

T A ReeseDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
B S WakemanEmory University Vaccine Center, Atlanta, GA 30322, USA.
H S ChoiDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA.
M M HuffordDepartments of Pediatrics and Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
S C HuangDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
X ZhangDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
M D BuckDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
A JezewskiDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
A KambalDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
C Y LiuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
G GoelCenter for Computational and Integrative Biology and Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
P J MurrayDepartments of Infectious Diseases and Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
R J XavierCenter for Computational and Integrative Biology and Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
M H KaplanDepartments of Pediatrics and Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
R RenneDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA.
S H SpeckEmory University Vaccine Center, Atlanta, GA 30322, USA.
M N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
E J PearceDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
H W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. virgin@wustl.edu.
Washington University in St. Louis · USMassachusetts General Hospital · USUniversity of Florida · USSt. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Virology and Smallpox VaccinationsU54AI057160 · NIAID · WASHINGTON UNIVERSITY · PI RAY, RANJIT · 2003 to 2013
$80.9M
SCHISTOSOME EGG-INDUCED TH2 RESPONSESR01AI032573 · NIAID · WASHINGTON UNIVERSITY · PI PEARCE, EDWARD J. · 1993 to 2016
$5.4M
Cytokine regulation of skin barrier functionR01AI095282 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2022
$4.3M
Control of Gammaherpesvirus ReplicationR01CA052004 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 1990 to 2013
$4.1M
Studying the role of KSHV-encoded miRNAsR01CA119917 · NCI · UNIVERSITY OF FLORIDA · PI RENNE, ROLF F · 2008 to 2017
$3.2M
T Cell Vaccination Against gamma-herpesvirus LatencyR01CA096511 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 2002 to 2012
$2.4M
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASER01AI084887 · NIAID · WASHINGTON UNIVERSITY · PI STAPPENBECK, THADDEUS S, VIRGIN, HERBERT W · 2010 to 2014
$1.9M
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITYR01CA164062 · NCI · WASHINGTON UNIVERSITY · PI PEARCE, EDWARD J. · 2012 to 2016
$1.7M
Schistosome egg induced TH2 responsesR56AI032573 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PEARCE, EDWARD J. · 2007 to 2007
$394k
NCI NIH HHS CA119917NCI NIH HHS CA164062NCI NIH HHS CA52004NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA052004NCI NIH HHS R01 CA096511NCI NIH HHS R01 CA119917NCI NIH HHS R01 CA164062NIAID NIH HHS AI032573NIAID NIH HHS AI084887NIAID NIH HHS R01 AI032573NIAID NIH HHS R01 AI084887NIAID NIH HHS R01 AI095282NIAID NIH HHS R56 AI032573NIAID NIH HHS U54 AI057160
6 · The paper itself

Abstract

Mammals are coinfected by multiple pathogens that interact through unknown mechanisms. We found that helminth infection, characterized by the induction of the cytokine interleukin-4 (IL-4) and the activation of the transcription factor Stat6, reactivated murine γ-herpesvirus infection in vivo. IL-4 promoted viral replication and blocked the antiviral effects of interferon-γ (IFNγ) by inducing Stat6 binding to the promoter for an important viral transcriptional transactivator. IL-4 also reactivated human Kaposi's sarcoma-associated herpesvirus from latency in cultured cells. Exogenous IL-4 plus blockade of IFNγ reactivated latent murine γ-herpesvirus infection in vivo, suggesting a "two-signal" model for viral reactivation. Thus, chronic herpesvirus infection, a component of the mammalian virome, is regulated by the counterpoised actions of multiple cytokines on viral promoters that have evolved to sense host immune status.

Indexed as

AnimalsGammaherpesvirinaeGene Expression Regulation, ViralHerpesvirus 8, HumanHumansInterferon-gammaInterleukin-4MacrophagesMiceMice, Inbred C57BLNematospiroides dubiusOvumPromoter Regions, GeneticSchistosoma mansoniSchistosomiasis mansoniSTAT6 Transcription FactorInterferon-gammaInterleukin-4Stat6 protein, mouseSTAT6 Transcription Factor

Identifiers

PMID24968940
PMCPMC4531374
OpenAlexW2047971723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.